This content is machine translated Atrial fibrillation Early rhythm control aims for better outcomes In patients with newly diagnosed AF, early initiation of rhythm control may reduce cardiovascular outcomes. Therapy with antiarrhythmic drugs and/or catheter ablation reduced cardiovascular deaths, strokes, and hospitalizations caused by…
View Post 4 min This content is machine translated Primary prevention of atherosclerosis Non-HDL cholesterol associated with long-term risk The criteria for cardiovascular risk stratification defined in the current guidelines of the European Society of Cardiology (ESC) form the basis for the calculation of an individual risk score. Non-HDL…
View Post 3 min This content is machine translated Alzheimer's and Co. Effective blood pressure therapy keeps dementia risk in check Dementia is an expression and consequence of various diseases. Due to demographic change, the prevalence is steadily increasing. A few years ago, it was possible to uncover a link between…
View Post 3 min This content is machine translated Diabetes Therapy Do GLP-1 receptor agonists contribute to stroke prophylaxis? The risk of suffering a stroke is massively higher for diabetics than in the general population. New data suggest that dulaglutide reduces the risk of ischemic stroke in diabetic patients…
View Post 4 min This content is machine translated Diabetes mellitus type 2 New Swiss guidelines support cardiovascular disease control The treatment of type 2 diabetes mellitus has undergone a transformation in recent years with the approval of new drug classes. The focus is no longer on pure glycemic control,…
View Post 5 min This content is machine translated Chronic coronary syndrome Risk stratification in coronary artery disease – an update. Coronary CT is highly ranked for the work-up algorithm in the updated European Society of Cardiology (ESC) guidelines. Calcification is an important prognostic indicator and has therapeutic implications. Among other…
View Post 6 min This content is machine translated COPD therapy Biomarkers could facilitate many things 22-40% of all COPD patients experience at least one moderate or severe exacerbation annually. Patients with frequent exacerbations have a worse prognosis. A team of researchers has been looking at…
View Post 4 min This content is machine translated COVID-19 and cardiovascular disease. Current findings and expert cardiological opinion on ACE inhibitors and ARBs. There is some uncertainty among patients and experts as to whether ACE inhibitors and ARBs are associated with an increased risk. Empirical data on this are inconsistent, but there are…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 11 min This content is machine translated Hypertension in practice High blood pressure – What the family doctor needs to know After a confirmed diagnosis of arterial hypertension, one should assess the severity, overall cardiovascular risk, and any organ damage present. First-line antihypertensives are RAAS blockers alone or combined with Ca…
View Post 7 min This content is machine translated "The lower the better" New AGLA Pocket Guide “Prevention of Atherosclerosis To reduce the risk of cardiovascular disease, low LDL-C levels are critical [1]. This finding is also reflected in the ESC/EAS Dyslipidemia Guidelines – the basis for the new Swiss…
